S&P 500   3,452.82 (+0.50%)
DOW   28,366.07 (+0.55%)
QQQ   284.30 (+0.04%)
AAPL   115.59 (-1.10%)
MSFT   214.86 (+0.03%)
FB   278.27 (-0.17%)
GOOGL   1,608.82 (+1.44%)
AMZN   3,168.55 (-0.51%)
TSLA   430.83 (+1.94%)
NVDA   536.68 (-0.80%)
BABA   306.37 (-0.52%)
CGC   19.91 (+2.15%)
GE   7.70 (+5.19%)
MU   54.75 (+2.70%)
AMD   79.79 (+0.74%)
T   28.29 (+5.88%)
F   8.15 (+3.82%)
ACB   4.74 (-2.27%)
GILD   60.24 (+0.05%)
NFLX   484.00 (-1.03%)
BA   168.95 (+3.11%)
NIO   27.22 (-2.30%)
DIS   127.96 (+1.05%)
S&P 500   3,452.82 (+0.50%)
DOW   28,366.07 (+0.55%)
QQQ   284.30 (+0.04%)
AAPL   115.59 (-1.10%)
MSFT   214.86 (+0.03%)
FB   278.27 (-0.17%)
GOOGL   1,608.82 (+1.44%)
AMZN   3,168.55 (-0.51%)
TSLA   430.83 (+1.94%)
NVDA   536.68 (-0.80%)
BABA   306.37 (-0.52%)
CGC   19.91 (+2.15%)
GE   7.70 (+5.19%)
MU   54.75 (+2.70%)
AMD   79.79 (+0.74%)
T   28.29 (+5.88%)
F   8.15 (+3.82%)
ACB   4.74 (-2.27%)
GILD   60.24 (+0.05%)
NFLX   484.00 (-1.03%)
BA   168.95 (+3.11%)
NIO   27.22 (-2.30%)
DIS   127.96 (+1.05%)
S&P 500   3,452.82 (+0.50%)
DOW   28,366.07 (+0.55%)
QQQ   284.30 (+0.04%)
AAPL   115.59 (-1.10%)
MSFT   214.86 (+0.03%)
FB   278.27 (-0.17%)
GOOGL   1,608.82 (+1.44%)
AMZN   3,168.55 (-0.51%)
TSLA   430.83 (+1.94%)
NVDA   536.68 (-0.80%)
BABA   306.37 (-0.52%)
CGC   19.91 (+2.15%)
GE   7.70 (+5.19%)
MU   54.75 (+2.70%)
AMD   79.79 (+0.74%)
T   28.29 (+5.88%)
F   8.15 (+3.82%)
ACB   4.74 (-2.27%)
GILD   60.24 (+0.05%)
NFLX   484.00 (-1.03%)
BA   168.95 (+3.11%)
NIO   27.22 (-2.30%)
DIS   127.96 (+1.05%)
S&P 500   3,452.82 (+0.50%)
DOW   28,366.07 (+0.55%)
QQQ   284.30 (+0.04%)
AAPL   115.59 (-1.10%)
MSFT   214.86 (+0.03%)
FB   278.27 (-0.17%)
GOOGL   1,608.82 (+1.44%)
AMZN   3,168.55 (-0.51%)
TSLA   430.83 (+1.94%)
NVDA   536.68 (-0.80%)
BABA   306.37 (-0.52%)
CGC   19.91 (+2.15%)
GE   7.70 (+5.19%)
MU   54.75 (+2.70%)
AMD   79.79 (+0.74%)
T   28.29 (+5.88%)
F   8.15 (+3.82%)
ACB   4.74 (-2.27%)
GILD   60.24 (+0.05%)
NFLX   484.00 (-1.03%)
BA   168.95 (+3.11%)
NIO   27.22 (-2.30%)
DIS   127.96 (+1.05%)
Log in
LON:CSRT

Consort Medical plc (CSRT.L) Share Forecast, Price & News

GBX 1,010
+5.00 (+0.50 %)
(As of 03/5/2020)
Add
Compare
Today's Range
1,005
Now: GBX 1,010▼
1,010
50-Day Range
1,010
MA: GBX 1,010▼
1,010
52-Week Range
702
Now: GBX 1,010▼
1,075
Volume768 shs
Average Volume520,697 shs
Market Capitalization£504.60 million
P/E Ratio127.85
Dividend Yield2.75%
BetaN/A
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is headquartered in Hemel Hempstead, the United Kingdom.
Read More
Consort Medical plc (CSRT.L) logo

Beat the Market (BTM) Rank™

Analyst Opinion: 1.0Community Rank: 3.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.13 out of 5 stars

Industry, Sector and Symbol

Stock Exchange LON
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolLON:CSRT
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.consortmedical.com
Phone+44-1442-867920
EmployeesN/A

Debt

Debt-to-Equity Ratio55.58
Current Ratio1.83
Quick Ratio1.16

Price-To-Earnings

Trailing P/E Ratio127.85
Forward P/E Ratio0.16
P/E GrowthN/A

Sales & Book Value

Annual Sales£298.60 million
Price / Sales1.69
Cash FlowGBX 30.20 per share
Price / Cash Flow33.44
Book ValueGBX 465.50 per share
Price / Book2.17

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares49,960,600
Market Cap£504.60 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 1,010
+5.00 (+0.50 %)
(As of 03/5/2020)
30 days | 90 days | 365 days | Advanced Chart

Receive CSRT News and Ratings via Email

Sign-up to receive the latest news and ratings for CSRT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Consort Medical plc (CSRT.L) (LON:CSRT) Frequently Asked Questions

How has Consort Medical plc (CSRT.L)'s stock price been impacted by Coronavirus (COVID-19)?

Consort Medical plc (CSRT.L)'s stock was trading at GBX 1,010 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CSRT shares have increased by 0.0% and is now trading at GBX 1,010.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Consort Medical plc (CSRT.L)?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Consort Medical plc (CSRT.L) in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Consort Medical plc (CSRT.L).

What price target have analysts set for CSRT?

2 brokers have issued 12 month target prices for Consort Medical plc (CSRT.L)'s stock. Their forecasts range from GBX 1,010 to GBX 1,010. On average, they anticipate Consort Medical plc (CSRT.L)'s share price to reach GBX 1,010 in the next year.
View analysts' price targets for Consort Medical plc (CSRT.L).

Who are some of Consort Medical plc (CSRT.L)'s key competitors?

Some companies that are related to Consort Medical plc (CSRT.L) include Corindus Vascular Robotics (CVRS), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group Plc (LID.L) (LID), InspireMD (NSPR), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).
View all competitors.

What other stocks do shareholders of Consort Medical plc (CSRT.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Consort Medical plc (CSRT.L) investors own include Chubb (CB), Newcrest Mining (NCM), Petrel Resources (PET), Barrick Gold Co. (ABX.TO) (ABX), Ascot Mining Plc Lon (ATMGF), BK IRELAND GRP/ADR (BKRIY), Caleres (CAL), Choice Hotels International (CHH), Colony Capital (CLNY) and JD Sports Fashion (JD).

Who are Consort Medical plc (CSRT.L)'s key executives?

Consort Medical plc (CSRT.L)'s management team includes the following people:
  • Mr. Jonathan M. Glenn, CEO & Director (Age 50)
  • Mr. Paul Hayes, CFO & Exec. Director (Age 52)
  • Mr. Andrew Jackson, Group Gen. Counsel & Company Sec.
  • Ms. Lisa King, Director of HR
  • Colin Leeder, Group Financial Controller

What is Consort Medical plc (CSRT.L)'s stock symbol?

Consort Medical plc (CSRT.L) trades on the London Stock Exchange (LON) under the ticker symbol "CSRT."

How do I buy shares of Consort Medical plc (CSRT.L)?

Shares of CSRT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Consort Medical plc (CSRT.L)'s stock price today?

One share of CSRT stock can currently be purchased for approximately GBX 1,010.

How big of a company is Consort Medical plc (CSRT.L)?

Consort Medical plc (CSRT.L) has a market capitalization of £504.60 million and generates £298.60 million in revenue each year.

What is Consort Medical plc (CSRT.L)'s official website?

The official website for Consort Medical plc (CSRT.L) is www.consortmedical.com.

How can I contact Consort Medical plc (CSRT.L)?

Consort Medical plc (CSRT.L)'s mailing address is Ste D, Breakspear Park, Breakspear Way, HEMEL HEMPSTEAD, HP2 4TZ, United Kingdom. The company can be reached via phone at +44-1442-867920.

This page was last updated on 10/22/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.